New shoulder implant shows promise for arthritis patients

NCT ID NCT02405208

First seen Jan 04, 2026 · Last updated Jun 23, 2026 · Updated 26 times

Summary

This study tested a new shoulder implant called PyroTITAN HRA in 156 people with arthritis. The implant resurfaces the ball part of the shoulder joint to relieve pain and improve function. Researchers tracked how long the device lasted and whether it caused problems, aiming to see if it's a good option for shoulder arthritis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Barwon Health

    Geelong, Victoria, 3220, Australia

  • Brisbane Hand & Upper Limb Clinic

    Brisbane, Queensland, 4001, Australia

  • Danderyd Hospital

    Stockholm, S-182 88, Sweden

  • Institut Nices

    Nice, 06000, France

  • Wrightington Hospital

    Wigan, Wrightington, WN6 9EP, United Kingdom

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

PyroTITAN HRA shoulder implant (a device that resurfaces the humeral head of the shoulder joint)

What this could lead to

If successful, this implant could provide a durable option for shoulder arthritis patients, potentially delaying or avoiding the need for a full shoulder replacement.

What could go wrong

This is a completed study with 156 participants, but it was not randomized or blinded, so results may be less reliable. The implant may fail over time, requiring additional surgery.

Conditions

The condition(s) this trial relates to.

arthritic joint disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.